written by reader The Gain from Pain Mainly Explained (part one)

by DrKSSMDPhD | July 15, 2014 4:15 pm

Guest Columnist Dr. KSS begins a series on pain

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://www.stockgumshoe.com/2014/07/the-gain-from-pain-mainly-explained-part-one/


776 responses to “written by reader The Gain from Pain Mainly Explained (part one)”

  1. DrKSSMDPhD says:

    $TRGT down 25 per cent today.

    I have warned people here FOR MONTHS with a consistent message: AVOID this stock (even as a poseur here was touting it).

    I said months ago that its Alzheimers, overactive bladder and gastroparesis drugs were utter nonsense. Since that time the AD drug has failed, and the OAB drug has been abandoned.

    What do you think will happen next?

  2. jonken says:

    Dr . KSS …
    Any thoughts about the reports on Malaria pills on PLOS Medicine? I didn’t see the name of any particular company but then I didn’t study the entire article, yet.
    http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001685
    Many thanks, as always,
    Ken M.

  3. Dan says:

    Diana,
    Okay, you can be President but I have dibs on Treasurer. 🙂

  4. Elliot says:

    I read the Celladon (CLDN) conference call this morning and was quite pleased with their clarity. Working on the Amicus (FOLD) conference call right now, but this one is harder for me to follow. Doc, are you still working on an article about Amicus? I’m eager to understand this stuff more!

    P.S. I still can’t believe CLDN stock’s day yesterday … did anyone pick up on institutional buying or anything?

  5. Elliot says:

    Benitec up 20% … wtf?

  6. Elliot says:

    BTX is breaking out on heavy volume today after getting hit hard early on. If it can hold above 3.00/share, it could finally buck this downtrend. I do think things are coming together for them over the past few months, and I am excited about their potential.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.